Guest: Miroslav Backonja, MD

Find the full Prescribing Information here.

Diabetic peripheral neuropathy occurs in approximately 30 percent of patients with diabetes, and half of those patients proceed to develop painful symptoms. Explore what those symptoms are and the mechanisms that lead to the development of painful diabetic peripheral neuropathy with Dr. Misha Backonja.

QUTENZA® is a registered trademark of Averitas Pharma, Inc.©
2021 Averitas Pharma, Inc. All rights reserved.
M-QZA-US-05-21-0005 May 2021